Cellectar Corp - חוב לטווח קצר של החברה CLRB
Cellectar Biosciences (CLRB) attracts rare radiochemists through premium bonuses and scientific prestige. The company's short-term debt dynamics illustrate working capital management, where the value of 0.00 expresses the metric level. Efficient isotope aviation logistics support the business, although the expansion of pharma behemoths into radiopharmaceuticals intensifies the struggle for patents and specialized laboratories.
%3A%20%D7%94%D7%9C%D7%95%D7%95%D7%90%D7%95%D7%AA%20%D7%95%D7%90%D7%A9%D7%A8%D7%90%D7%99%20%D7%9C%D7%98%D7%95%D7%95%D7%97%20%D7%A7%D7%A6%D7%A8%20%D7%A9%D7%9C%20%D7%94%D7%97%D7%91%D7%A8%D7%94&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_CLRB_-_Cellectar-Biosciences_-_Company-Short-Term-Loans-and-Borrowings "CLRB Cellectar Biosciences: חובות לטווח קצר של החברה בטווח 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
Cellectar Corp - פילוחים אנליטיים ומדדי מפתח (CLRB)
Portfolio managers are evaluating the operating model of Cellectar Biosciences (CLRB) through the lens of short-term liquidity, where this metric measures the speed of meeting current obligations and the inertia of the credit load. An analysis of short-term liabilities confirms the financial stability of the radiopharmaceutical aviation logistics, ensuring that the express delivery of isotopes is supported by stable capital without the need for emergency asset sales to cover debts.